
← Off the Couch Psychology1 sep · 27 min
PMDD: More Than Bad PMS
For years, severe premenstrual symptoms were sometimes dismissed as simply "bad PMS." But Premenstrual Dysphoric Disorder—PMDD—is a recognized disorder that can seriously affect mood, relationships, work, and everyday functioning.
In this episode of Off the Couch Psychology Podcast, you'll learn what separates PMDD from typical PMS, why the timing and pattern of symptoms are so important, and why the problem may involve the brain's response to normal hormonal fluctuations rather than simply having "too many hormones." You'll also meet Connie and see how PMDD can play out in everyday life when ordinary situations suddenly feel much harder to manage.
Most importantly, we'll explore what can actually help. From symptom tracking and therapy to SSRIs, hormonal approaches, lifestyle strategies, and emerging areas of research, you'll get a practical introduction to the treatment options being studied and used today.
If you—or someone you care about—seems to become a dramatically different person during the same part of the menstrual cycle each month, this episode may help you understand why.
Suggested Reading & References American College of Obstetricians and Gynecologists (ACOG), "What I Wish Everyone Knew About Premenstrual Dysphoric Disorder." A listener-friendly overview of PMDD symptoms and treatment. (ACOG)
Read the ACOG PMDD overview
American College of Obstetricians and Gynecologists (ACOG), Clinical Practice Guideline: Management of Premenstrual Disorders. Evidence-based guidance covering diagnosis and pharmacologic, psychological, lifestyle, and other treatment approaches. (ACOG)
Read the ACOG clinical guideline
Mishra, S., Elliott, H., & Marwaha, R., "Premenstrual Dysphoric Disorder," StatPearls. Reviews diagnostic criteria, symptom patterns, biology, assessment, and treatment. (NCBI)
Read the StatPearls PMDD review
Cochrane Review, "Selective Serotonin Reuptake Inhibitors for Premenstrual Syndrome and Premenstrual Dysphoric Disorder." Reviews evidence for SSRI treatment, including continuous and luteal-phase dosing. (PubMed)
View the review on PubMed